Cisatracurium besylate injection has a market value of approximately $14 million in the 12 months ending January 2025, per ...
Hikma Pharmaceuticals PLC HIK shares slipped 1.68% to £19.86 Monday, on what proved to be an all-around rough trading session ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback